Eli Lilly (LLY) EBT Margin Growth (1y) (2010 - 2026)
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBT Margin Growth (1y) (Qtr) |
| 1 |
Novartis Ag |
107,124,802.25 Bn |
107,124,802.25 Bn |
- |
- |
| 2 |
Eli Lilly |
969.00 Bn |
963.72 Bn |
16.22 Bn |
1,755.00 |
| 3 |
Johnson & Johnson |
539.46 Bn |
517.41 Bn |
15.96 Bn |
-3,737.00 |
| 4 |
AbbVie |
376.92 Bn |
367.57 Bn |
10.78 Bn |
-552.00 |
| 5 |
Merck |
285.00 Bn |
279.35 Bn |
12.09 Bn |
-5,950.00 |
| 6 |
Amgen |
177.58 Bn |
165.55 Bn |
5.87 Bn |
-3.00 |
| 7 |
Gilead Sciences |
163.22 Bn |
155.50 Bn |
5.52 Bn |
1,234.00 |
| 8 |
Pfizer |
145.86 Bn |
133.09 Bn |
-1.21 Bn |
372.00 |
| 9 |
Bristol Myers Squibb |
111.90 Bn |
101.44 Bn |
8.07 Bn |
168.00 |
| 10 |
Gsk |
88.34 Bn |
83.66 Bn |
- |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
1,755.00 |
| Dec 31, 2025 |
562.00 |
| Sep 30, 2025 |
2,721.00 |
| Jun 30, 2025 |
1,244.00 |
| Mar 31, 2025 |
-177.00 |
| Dec 31, 2024 |
1,041.00 |
| Sep 30, 2024 |
939.00 |
| Jun 30, 2024 |
599.00 |
| Mar 31, 2024 |
695.00 |
| Dec 31, 2023 |
-189.00 |
| Sep 30, 2023 |
-1,805.00 |
| Jun 30, 2023 |
832.00 |
| Mar 31, 2023 |
-432.00 |
| Dec 31, 2022 |
571.00 |
| Sep 30, 2022 |
417.00 |
| Jun 30, 2022 |
-683.00 |
| Mar 31, 2022 |
460.00 |
| Dec 31, 2021 |
-1,019.00 |
| Sep 30, 2021 |
-665.00 |
| Jun 30, 2021 |
-624.00 |
| Mar 31, 2021 |
-697.00 |
| Dec 31, 2020 |
599.00 |
| Sep 30, 2020 |
-63.00 |
| Jun 30, 2020 |
388.00 |
| Mar 31, 2020 |
1,431.00 |
| Dec 31, 2019 |
1,068.00 |
| Sep 30, 2019 |
40.00 |
| Jun 30, 2019 |
2,526.00 |
| Mar 31, 2019 |
-1,316.00 |
| Dec 31, 2018 |
1,017.00 |
| Sep 30, 2018 |
1,481.00 |
| Jun 30, 2018 |
-2,090.00 |
| Mar 31, 2018 |
2,634.00 |
| Dec 31, 2017 |
-913.00 |
| Sep 30, 2017 |
-824.00 |
| Jun 30, 2017 |
417.00 |
| Mar 31, 2017 |
-1,048.00 |
| Dec 31, 2016 |
721.00 |
| Sep 30, 2016 |
-243.00 |
| Jun 30, 2016 |
382.00 |
| Mar 31, 2016 |
-165.00 |
| Dec 31, 2015 |
-176.00 |
| Sep 30, 2015 |
768.00 |
| Jun 30, 2015 |
-540.00 |
| Mar 31, 2015 |
-572.00 |
| Dec 31, 2014 |
-564.00 |
| Sep 30, 2014 |
-1,277.00 |
| Jun 30, 2014 |
-649.00 |
| Mar 31, 2014 |
-1,581.00 |
| Dec 31, 2013 |
-133.00 |
| Sep 30, 2013 |
-822.00 |
| Jun 30, 2013 |
438.00 |
| Mar 31, 2013 |
1,099.00 |
| Dec 31, 2012 |
-24.00 |
| Sep 30, 2012 |
1,000.00 |
| Jun 30, 2012 |
-332.00 |
| Mar 31, 2012 |
202.00 |
| Dec 31, 2011 |
-555.00 |
| Sep 30, 2011 |
-602.00 |
| Jun 30, 2011 |
-658.00 |
| Mar 31, 2011 |
-932.00 |
| Dec 31, 2010 |
362.00 |
| Sep 30, 2010 |
1,060.00 |
| Jun 30, 2010 |
334.00 |
| Mar 31, 2010 |
-222.00 |
